Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests: The EuroPrevall birth cohort

Linus B. Grabenhenrich, Andreas Reich, Doreen McBride, Aline Sprikkelman, Graham Roberts, Kate E.C. Grimshaw, Alessandro G. Fiocchi, Photini Saxoni-Papageorgiou, Nikolaos G. Papadopoulos, Ana Fiandor, Santiago Quirce, Marek L. Kowalski, Sigurveig T. Sigurdardottir, Ruta Dubakiene, Jonathan O.B. Hourihane, Leonard Rosenfeld, Bodo Niggemann, Thomas Keil, Kirsten Beyer

Research output: Contribution to journalArticle

Abstract

Background: Blinded food challenges are considered the current gold standard for the diagnosis of food allergies. We used data from a pan-European multicenter project to assess differences between study centers, aiming to identify the impact of subjective aspects for the interpretation of oral food challenges. Methods: Nine study centers of the EuroPrevall birth cohort study about food allergy recruited 12 049 newborns and followed them for up to 30 months in regular intervals. Intensive training was conducted and every center visited to ensure similar handling of the protocols. Suspected food allergy was clinically evaluated by double-blind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms. Results: Of 839 challenges conducted, study centers confirmed food allergy in 15.6% to 53.6% of locally conducted challenges. Centers reported 0 to 16 positive placebo challenges. Worsening of eczema was the most common sign when challenged with placebo. Agreement between documented objective signs and the challenge outcome assigned by the physician was heterogeneous, with Cohen's kappa spanning from 0.42 to 0.84. Conclusions: These differences suggest that the comparison of food challenge outcomes between centers is difficult despite common protocols and training. We recommend detailed symptom assessment and documentation as well as objective sign-based challenge outcome algorithms to assure accuracy and comparability of blinded food challenges. Training and supervision of staff conducting food challenges is a mandatory component of reliable outcome data.

Original languageEnglish
Pages (from-to)58-65
Number of pages8
JournalPediatric Allergy and Immunology
Volume29
Issue number1
DOIs
Publication statusPublished - Oct 6 2017

Fingerprint

Food Hypersensitivity
Physicians
Food
Placebos
Birthing Centers
Symptom Assessment
Eczema
Documentation
Signs and Symptoms
Cohort Studies
Newborn Infant

Keywords

  • data collection
  • decision-making
  • diagnostic techniques and procedures
  • food hypersensitivity
  • observer variation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Immunology

Cite this

Grabenhenrich, L. B., Reich, A., McBride, D., Sprikkelman, A., Roberts, G., Grimshaw, K. E. C., ... Beyer, K. (2017). Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests: The EuroPrevall birth cohort. Pediatric Allergy and Immunology, 29(1), 58-65. https://doi.org/10.1111/pai.12811

Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests : The EuroPrevall birth cohort. / Grabenhenrich, Linus B.; Reich, Andreas; McBride, Doreen; Sprikkelman, Aline; Roberts, Graham; Grimshaw, Kate E.C.; Fiocchi, Alessandro G.; Saxoni-Papageorgiou, Photini; Papadopoulos, Nikolaos G.; Fiandor, Ana; Quirce, Santiago; Kowalski, Marek L.; Sigurdardottir, Sigurveig T.; Dubakiene, Ruta; Hourihane, Jonathan O.B.; Rosenfeld, Leonard; Niggemann, Bodo; Keil, Thomas; Beyer, Kirsten.

In: Pediatric Allergy and Immunology, Vol. 29, No. 1, 06.10.2017, p. 58-65.

Research output: Contribution to journalArticle

Grabenhenrich, LB, Reich, A, McBride, D, Sprikkelman, A, Roberts, G, Grimshaw, KEC, Fiocchi, AG, Saxoni-Papageorgiou, P, Papadopoulos, NG, Fiandor, A, Quirce, S, Kowalski, ML, Sigurdardottir, ST, Dubakiene, R, Hourihane, JOB, Rosenfeld, L, Niggemann, B, Keil, T & Beyer, K 2017, 'Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests: The EuroPrevall birth cohort', Pediatric Allergy and Immunology, vol. 29, no. 1, pp. 58-65. https://doi.org/10.1111/pai.12811
Grabenhenrich, Linus B. ; Reich, Andreas ; McBride, Doreen ; Sprikkelman, Aline ; Roberts, Graham ; Grimshaw, Kate E.C. ; Fiocchi, Alessandro G. ; Saxoni-Papageorgiou, Photini ; Papadopoulos, Nikolaos G. ; Fiandor, Ana ; Quirce, Santiago ; Kowalski, Marek L. ; Sigurdardottir, Sigurveig T. ; Dubakiene, Ruta ; Hourihane, Jonathan O.B. ; Rosenfeld, Leonard ; Niggemann, Bodo ; Keil, Thomas ; Beyer, Kirsten. / Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests : The EuroPrevall birth cohort. In: Pediatric Allergy and Immunology. 2017 ; Vol. 29, No. 1. pp. 58-65.
@article{6a5f7ffb67c742a88c06c9e16b181ffd,
title = "Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests: The EuroPrevall birth cohort",
abstract = "Background: Blinded food challenges are considered the current gold standard for the diagnosis of food allergies. We used data from a pan-European multicenter project to assess differences between study centers, aiming to identify the impact of subjective aspects for the interpretation of oral food challenges. Methods: Nine study centers of the EuroPrevall birth cohort study about food allergy recruited 12 049 newborns and followed them for up to 30 months in regular intervals. Intensive training was conducted and every center visited to ensure similar handling of the protocols. Suspected food allergy was clinically evaluated by double-blind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms. Results: Of 839 challenges conducted, study centers confirmed food allergy in 15.6{\%} to 53.6{\%} of locally conducted challenges. Centers reported 0 to 16 positive placebo challenges. Worsening of eczema was the most common sign when challenged with placebo. Agreement between documented objective signs and the challenge outcome assigned by the physician was heterogeneous, with Cohen's kappa spanning from 0.42 to 0.84. Conclusions: These differences suggest that the comparison of food challenge outcomes between centers is difficult despite common protocols and training. We recommend detailed symptom assessment and documentation as well as objective sign-based challenge outcome algorithms to assure accuracy and comparability of blinded food challenges. Training and supervision of staff conducting food challenges is a mandatory component of reliable outcome data.",
keywords = "data collection, decision-making, diagnostic techniques and procedures, food hypersensitivity, observer variation",
author = "Grabenhenrich, {Linus B.} and Andreas Reich and Doreen McBride and Aline Sprikkelman and Graham Roberts and Grimshaw, {Kate E.C.} and Fiocchi, {Alessandro G.} and Photini Saxoni-Papageorgiou and Papadopoulos, {Nikolaos G.} and Ana Fiandor and Santiago Quirce and Kowalski, {Marek L.} and Sigurdardottir, {Sigurveig T.} and Ruta Dubakiene and Hourihane, {Jonathan O.B.} and Leonard Rosenfeld and Bodo Niggemann and Thomas Keil and Kirsten Beyer",
year = "2017",
month = "10",
day = "6",
doi = "10.1111/pai.12811",
language = "English",
volume = "29",
pages = "58--65",
journal = "Pediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - Physician's appraisal vs documented signs and symptoms in the interpretation of food challenge tests

T2 - The EuroPrevall birth cohort

AU - Grabenhenrich, Linus B.

AU - Reich, Andreas

AU - McBride, Doreen

AU - Sprikkelman, Aline

AU - Roberts, Graham

AU - Grimshaw, Kate E.C.

AU - Fiocchi, Alessandro G.

AU - Saxoni-Papageorgiou, Photini

AU - Papadopoulos, Nikolaos G.

AU - Fiandor, Ana

AU - Quirce, Santiago

AU - Kowalski, Marek L.

AU - Sigurdardottir, Sigurveig T.

AU - Dubakiene, Ruta

AU - Hourihane, Jonathan O.B.

AU - Rosenfeld, Leonard

AU - Niggemann, Bodo

AU - Keil, Thomas

AU - Beyer, Kirsten

PY - 2017/10/6

Y1 - 2017/10/6

N2 - Background: Blinded food challenges are considered the current gold standard for the diagnosis of food allergies. We used data from a pan-European multicenter project to assess differences between study centers, aiming to identify the impact of subjective aspects for the interpretation of oral food challenges. Methods: Nine study centers of the EuroPrevall birth cohort study about food allergy recruited 12 049 newborns and followed them for up to 30 months in regular intervals. Intensive training was conducted and every center visited to ensure similar handling of the protocols. Suspected food allergy was clinically evaluated by double-blind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms. Results: Of 839 challenges conducted, study centers confirmed food allergy in 15.6% to 53.6% of locally conducted challenges. Centers reported 0 to 16 positive placebo challenges. Worsening of eczema was the most common sign when challenged with placebo. Agreement between documented objective signs and the challenge outcome assigned by the physician was heterogeneous, with Cohen's kappa spanning from 0.42 to 0.84. Conclusions: These differences suggest that the comparison of food challenge outcomes between centers is difficult despite common protocols and training. We recommend detailed symptom assessment and documentation as well as objective sign-based challenge outcome algorithms to assure accuracy and comparability of blinded food challenges. Training and supervision of staff conducting food challenges is a mandatory component of reliable outcome data.

AB - Background: Blinded food challenges are considered the current gold standard for the diagnosis of food allergies. We used data from a pan-European multicenter project to assess differences between study centers, aiming to identify the impact of subjective aspects for the interpretation of oral food challenges. Methods: Nine study centers of the EuroPrevall birth cohort study about food allergy recruited 12 049 newborns and followed them for up to 30 months in regular intervals. Intensive training was conducted and every center visited to ensure similar handling of the protocols. Suspected food allergy was clinically evaluated by double-blind, placebo-controlled food challenges using a nine dose escalation protocol. The primary challenge outcomes based on physician's appraisal were compared to documented signs and symptoms. Results: Of 839 challenges conducted, study centers confirmed food allergy in 15.6% to 53.6% of locally conducted challenges. Centers reported 0 to 16 positive placebo challenges. Worsening of eczema was the most common sign when challenged with placebo. Agreement between documented objective signs and the challenge outcome assigned by the physician was heterogeneous, with Cohen's kappa spanning from 0.42 to 0.84. Conclusions: These differences suggest that the comparison of food challenge outcomes between centers is difficult despite common protocols and training. We recommend detailed symptom assessment and documentation as well as objective sign-based challenge outcome algorithms to assure accuracy and comparability of blinded food challenges. Training and supervision of staff conducting food challenges is a mandatory component of reliable outcome data.

KW - data collection

KW - decision-making

KW - diagnostic techniques and procedures

KW - food hypersensitivity

KW - observer variation

UR - http://www.scopus.com/inward/record.url?scp=85041039372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041039372&partnerID=8YFLogxK

U2 - 10.1111/pai.12811

DO - 10.1111/pai.12811

M3 - Article

AN - SCOPUS:85041039372

VL - 29

SP - 58

EP - 65

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

SN - 0905-6157

IS - 1

ER -